ArticleBeilstein journal of nanotechnology2023
Solvent-induced assembly of mono- and divalent silica nanoparticles.
Article in Beilstein journal of nanotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Particles with attractive patches are appealing candidates to be used as building units to fabricate novel colloidal architectures by self-assembly. Here, we report the synthesis of one-patch silica nanoparticles, which consist of silica half-spheres whose concave face carries in its center a polymeric patch made of grafted polystyrene chains. The multistage synthesis allows for a fine control of the patch-to-particle size ratio from 0.23 to 0.57. The assembly of the patchy nanoparticles can be triggered by reducing the solvent quality for the polystyrene chains. Dimers or trimers can be obtained by tuning the patch-to-particle size ratio. When mixed with two-patch nanoparticles, one-patch nanoparticles control the length of the resulting chains by behaving as colloidal chain stoppers. The present strategy allows for future elaboration of novel colloidal structures by controlled assembly of nanoparticles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.